Recalls from AvKARE

• AvKARE Amitriptyline Hydrochloride Tablets (opens in a new tab)
  FDA, Oct 22, 2026, Drug dissolving problem
• AvKARE Amantadine HCl Capsules (opens in a new tab)
  Moderate risk, FDA, Feb 23, 2026, Drug dissolving problem
• AvKARE Rosuvastatin Tablets (opens in a new tab)
  Moderate risk, FDA, Jan 7, 2026, Drug dissolving problem

Data: Recall Canary (opens in a new tab)